Comparative pathogenicity of Coxsackievirus A16 circulating and noncirculating strains in vitro and in a neonatal mouse model

An enterovirus 71 (EV71) vaccine for the prevention of hand, foot, and mouth disease (HMFD) is available, but it is not known whether the EV71 vaccine cross-protects against Coxsackievirus (CV) infection. Furthermore, although an inactivated circulating CVA16 Changchun 024 (CC024) strain vaccine can...

Full description

Bibliographic Details
Main Authors: L. Huang, X. Liu, J.L. Li, J.L. Chang, G.C. Liu, X.F. Yu, W.Y. Zhang
Format: Article
Language:English
Published: Associação Brasileira de Divulgação Científica 2015-03-01
Series:Brazilian Journal of Medical and Biological Research
Subjects:
Online Access:http://www.scielo.br/pdf/bjmbr/v48n5/1414-431X-bjmbr-1414-431X20144298.pdf
_version_ 1798013828847370240
author L. Huang
X. Liu
J.L. Li
J.L. Chang
G.C. Liu
X.F. Yu
W.Y. Zhang
author_facet L. Huang
X. Liu
J.L. Li
J.L. Chang
G.C. Liu
X.F. Yu
W.Y. Zhang
author_sort L. Huang
collection DOAJ
description An enterovirus 71 (EV71) vaccine for the prevention of hand, foot, and mouth disease (HMFD) is available, but it is not known whether the EV71 vaccine cross-protects against Coxsackievirus (CV) infection. Furthermore, although an inactivated circulating CVA16 Changchun 024 (CC024) strain vaccine candidate is effective in newborn mice, the CC024 strain causes severe lesions in muscle and lung tissues. Therefore, an effective CV vaccine with improved pathogenic safety is needed. The aim of this study was to evaluate the in vivo safety and in vitro replication capability of a noncirculating CVA16 SHZH05 strain. The replication capacity of circulating CVA16 strains CC024, CC045, CC090 and CC163 and the noncirculating SHZH05 strain was evaluated by cytopathic effect in different cell lines. The replication capacity and pathogenicity of the CC024 and SHZH05 strains were also evaluated in a neonatal mouse model. Histopathological and viral load analyses demonstrated that the SHZH05 strain had an in vitro replication capacity comparable to the four CC strains. The CC024, but not the SHZH05 strain, became distributed in a variety of tissues and caused severe lesions and mortality in neonatal mice. The differences in replication capacity and in vivo pathogenicity of the CC024 and SHZH05 strains may result from differences in the nucleotide and amino acid sequences of viral functional polyproteins P1, P2 and P3. Our findings suggest that the noncirculating SHZH05 strain may be a safer CV vaccine candidate than the CC024 strain.
first_indexed 2024-04-11T15:08:55Z
format Article
id doaj.art-efb991efe11545d7904ea12b904ac7a3
institution Directory Open Access Journal
issn 1414-431X
language English
last_indexed 2024-04-11T15:08:55Z
publishDate 2015-03-01
publisher Associação Brasileira de Divulgação Científica
record_format Article
series Brazilian Journal of Medical and Biological Research
spelling doaj.art-efb991efe11545d7904ea12b904ac7a32022-12-22T04:16:43ZengAssociação Brasileira de Divulgação CientíficaBrazilian Journal of Medical and Biological Research1414-431X2015-03-0148542042610.1590/1414-431x20144298Comparative pathogenicity of Coxsackievirus A16 circulating and noncirculating strains in vitro and in a neonatal mouse modelL. HuangX. LiuJ.L. LiJ.L. ChangG.C. LiuX.F. YuW.Y. ZhangAn enterovirus 71 (EV71) vaccine for the prevention of hand, foot, and mouth disease (HMFD) is available, but it is not known whether the EV71 vaccine cross-protects against Coxsackievirus (CV) infection. Furthermore, although an inactivated circulating CVA16 Changchun 024 (CC024) strain vaccine candidate is effective in newborn mice, the CC024 strain causes severe lesions in muscle and lung tissues. Therefore, an effective CV vaccine with improved pathogenic safety is needed. The aim of this study was to evaluate the in vivo safety and in vitro replication capability of a noncirculating CVA16 SHZH05 strain. The replication capacity of circulating CVA16 strains CC024, CC045, CC090 and CC163 and the noncirculating SHZH05 strain was evaluated by cytopathic effect in different cell lines. The replication capacity and pathogenicity of the CC024 and SHZH05 strains were also evaluated in a neonatal mouse model. Histopathological and viral load analyses demonstrated that the SHZH05 strain had an in vitro replication capacity comparable to the four CC strains. The CC024, but not the SHZH05 strain, became distributed in a variety of tissues and caused severe lesions and mortality in neonatal mice. The differences in replication capacity and in vivo pathogenicity of the CC024 and SHZH05 strains may result from differences in the nucleotide and amino acid sequences of viral functional polyproteins P1, P2 and P3. Our findings suggest that the noncirculating SHZH05 strain may be a safer CV vaccine candidate than the CC024 strain.http://www.scielo.br/pdf/bjmbr/v48n5/1414-431X-bjmbr-1414-431X20144298.pdfCoxsackievirus A16PathogenicityCirculating strainNon-circulating strain
spellingShingle L. Huang
X. Liu
J.L. Li
J.L. Chang
G.C. Liu
X.F. Yu
W.Y. Zhang
Comparative pathogenicity of Coxsackievirus A16 circulating and noncirculating strains in vitro and in a neonatal mouse model
Brazilian Journal of Medical and Biological Research
Coxsackievirus A16
Pathogenicity
Circulating strain
Non-circulating strain
title Comparative pathogenicity of Coxsackievirus A16 circulating and noncirculating strains in vitro and in a neonatal mouse model
title_full Comparative pathogenicity of Coxsackievirus A16 circulating and noncirculating strains in vitro and in a neonatal mouse model
title_fullStr Comparative pathogenicity of Coxsackievirus A16 circulating and noncirculating strains in vitro and in a neonatal mouse model
title_full_unstemmed Comparative pathogenicity of Coxsackievirus A16 circulating and noncirculating strains in vitro and in a neonatal mouse model
title_short Comparative pathogenicity of Coxsackievirus A16 circulating and noncirculating strains in vitro and in a neonatal mouse model
title_sort comparative pathogenicity of coxsackievirus a16 circulating and noncirculating strains in vitro and in a neonatal mouse model
topic Coxsackievirus A16
Pathogenicity
Circulating strain
Non-circulating strain
url http://www.scielo.br/pdf/bjmbr/v48n5/1414-431X-bjmbr-1414-431X20144298.pdf
work_keys_str_mv AT lhuang comparativepathogenicityofcoxsackievirusa16circulatingandnoncirculatingstrainsinvitroandinaneonatalmousemodel
AT xliu comparativepathogenicityofcoxsackievirusa16circulatingandnoncirculatingstrainsinvitroandinaneonatalmousemodel
AT jlli comparativepathogenicityofcoxsackievirusa16circulatingandnoncirculatingstrainsinvitroandinaneonatalmousemodel
AT jlchang comparativepathogenicityofcoxsackievirusa16circulatingandnoncirculatingstrainsinvitroandinaneonatalmousemodel
AT gcliu comparativepathogenicityofcoxsackievirusa16circulatingandnoncirculatingstrainsinvitroandinaneonatalmousemodel
AT xfyu comparativepathogenicityofcoxsackievirusa16circulatingandnoncirculatingstrainsinvitroandinaneonatalmousemodel
AT wyzhang comparativepathogenicityofcoxsackievirusa16circulatingandnoncirculatingstrainsinvitroandinaneonatalmousemodel